Introduction
Human bone marrow (BM) mesenchymal/stromal stem cells (MSCs) are multipotent stromal cells that can differentiate into osteoblasts (OBs) and adipocytes [1] , and have the ability to expand hematopoietic stem and progenitor cells (HSPCs) when co-cultured in vitro [2, 3] . The ability of human BM-derived MSCs to support hematopoiesis has been validated in clinical trials in the setting of HSPC transplantation (HSCT) [4, 5] . Therefore, further research into the potential of BM-MSCs in hematopoiesis would lead to an improved outcome of HSCT.
By the use of genetic mouse models, stromal cells that show similar characteristics to MSCs were demonstrated to be crucial for physiological hematopoiesis in BM microenvironments [6, 7, 8, 9, 10] . In addition, the pathological hematopoiesis of myelodysplasia results from a primary genetic abnormality in osteoprogenitor cells [11] .
These findings imply that mouse osteoprogenitor cells are not simply in an intermediary differentiation stage between MSCs and OBs, but in a crucial functional stage for regulating hematopoiesis. However, the characteristics of such cells in humans are unknown.
The purpose of this study was to examine the hematopoiesis-supportive potential of early osteoinductive human BM-MSCs (e-MSCs) and to analyze the detailed gene expression profiles of these cells using microarray analysis.
Material and Methods

Culture and osteogenic differentiation of human BM-MSCs
Normal human BM samples that were obtained from healthy adult volunteers with informed consent were purchased from AllCells (Emeryville, CA). Human BM-MSCs were isolated and cultured based on a previously published method [3, 12, 13, 14, 15] . In brief, a single-cell suspension of 1×10 6 BM mononuclear cells 8
Microarray analysis
Total RNA (1 µg/sample) from control unstimulated BM-MSCs (ctrl-MSCs)
or BM-MSCs that were cultured in the osteoinductive medium for 2 days (e2-MSCs) or 5 days (e5-MSCs) was amplified using the Ambion Amino Allyl aRNA Kit (Ambion, Carlsbad, CA). Each sample of amplified RNA was labeled with Cy5, and labeled samples were co-hybridized with the 3D-Gene Human Oligo Chip 25k (Toray Industries, Tokyo, Japan) at 37°C for 16 hours. After washing the DNA chip, hybridization signals were scanned using a 3D-Gene Scanner 3000 (Toray Industries). All analyzed data were scaled by global normalization. Microarray data were analyzed using GeneSpring GX software (Tomy Digital Biology, Tokyo, Japan). All raw data were normalized and filtered based on the signal intensity values (20-100th percentile range). Hierarchical clustering and Gene ontology (GO) analysis was performed using GeneSpring GX software. Gene set enrichment analysis (GSEA) was performed using GSEA v2.0.14 software (http://www.broadinstitute.org/gsea/index.jsp). The gene set "Cell_Cell_Adhesion" was downloaded from the Molecular Signature Database (MSigDB; http://www.broadinstitute.org/gsea/msigdb/index.jsp). The genes included are listed in Supplementary Table 2 . The analysis parameters were as follows: the number of permutations was 1,000, the permutation type was set to gene set, the gene set size filters were set to min=15 and max=500, and the metric for ranking genes was
Diff_of_Classes. The complete microarray data are available in the NCBI Gene Expression Omnibus (GEO). The microarray accession number is 74837.
BM transplantation
Specific pathogen-free 6-8-week-old female C57BL/6 mice were purchased from CLEA Japan (Tokyo, Japan). BM nucleated cells (5×10 5 /mouse) from C57BL/6 mice were transplanted into lethally irradiated (9 Gy) recipient C57BL/6 mice. OICS (dissolved in PBS) or PBS (control) was administered intraperitoneally to recipient mice on days 1-7 after BM transplantation. The survival of mice was observed each day until day 35 after BM transplantation. Peripheral blood (PB) was collected on days 0, 4, 7, 10, 13, 17, 21, 25, 28, and 35 after BM transplantation (n = 6) from the tail veins, and the number of white blood cells (WBCs) and the hemoglobin (Hb) levels were analyzed using an automated blood cell counter (Celltac , Nihon Kohden, Tokyo, Japan). These studies were approved by the committee for animal research of the Kyoto University Graduate School of Medicine.
Statistical analysis
The unpaired Student's t-test was used for analysis, unless otherwise indicated.
Data in bar graphs indicate the mean ± SD, and statistical significance is expressed as follows: *, P < 0.05; **, P < 0.01.
Results
Characteristics of early osteoinductive human BM-MSCs (e-MSCs)
First, we cultured human BM-MSCs in osteoinductive medium and examined their mineralization by Alizarin Red S staining. Mineralization was observed following 10 days of culture (Fig. 1A) . Mineralization was not observed in BM-MSCs that were cultured in osteoinductive medium for just 2 or 5 days (Fig. 1A ). When these early osteoinductive MSCs (e-MSCs) were cultured in adipogenesis-inducing medium for more than 2 weeks, significant fat deposition was observed ( Fig. S1A-B) , indicating their adipogenic differentiation ability. Thus, BM-MSCs cultured in osteoinductive medium for just 2 days (e2-MSCs) or 5 days (e5-MSCs) were considered to be immature cells that were in a differentiation stage between MSCs and osteoprogenitor cells. This was further supported by the observations that e2-MSCs and e5-MSCs did not show decreased expression of stemness-associated markers (Fig. S1C ) or increased expression of osteogenesis-associated markers such as SP7 (also known as osterix), BGLAP (also known as osteocalcin), and SPP1 (also known as osteopontin) (Fig. S1D) by microarray analysis.
e-MSCs support an enhanced expansion of hematopoietic cells
To investigate the ability of osteoinductive BM-MSCs to support hematopoiesis, in vitro co-culture experiments with these cells and human CD34 + HSPCs were performed (Fig. 1B) . When BM-MSCs were cultured in osteoinductive medium for 2 days (i.e., e2-MSCs) or 5 days (i.e., e5-MSCs) and then co-cultured with
HSPCs for 10 days in the presence of SCF, Flt3-L, IL-3, and TPO, the expansion of CD45 + cells and CD34 + HSPCs was significantly enhanced in comparison to when they were co-cultured with control unstimulated BM-MSCs (ctrl-MSCs) ( Fig. 1C-D) . This enhanced hematopoietic expansion of these cells was not observed in co-cultures with BM-MSCs that were cultured in osteoinductive medium for 10 days (Fig. 1C-D 1F ). Because hematopoiesis is regulated by various types of soluble factors, we focused on cytokines that are related to hematopoiesis and analyzed the change in their expression. There was no apparent change in the expression of granulocyte macrophage colony-stimulation factor (also known as CSF2), granulocyte colony-stimulation factor (G-CSF, also known as CSF3), SCF (also known as KITLG), IL-3, FLT3LG, or EPO in e2-and e5-MSCs (Fig. 1G ).
We found that 358 genes were commonly down-regulated in e2-and e5-MSCs ( Fig. 2A) . GO analysis showed that these commonly down-regulated genes were significantly included in the GO term of "Cell adhesion" (accession number 0007155, Fig. 2B ). GSEA also revealed that the gene signature of Cell_Cell_Adhesion was negatively enriched in e2-and e5-MSCs (Fig. 2C) . We focused on cell adhesion-related genes that contribute to hematopoiesis and found that expression of most of them, especially vascular cell adhesion molecule 1 (VCAM1), was decreased in e2-and e5-MSCs (Fig. 2D ). Quantitative reverse transcription PCR (qRT-PCR) analysis validated the decrease in mRNA expression of VCAM1 (Fig. 2E ). This was further confirmed in e2-and e5-MSCs derived from different BM-MSC lots (Fig. S4A ). Thus, short-term osteogenic induction inhibits the contribution of the cell adhesion-associated mechanism by MSCs to hematopoietic regulation.
Expression of chemotaxis-associated genes is increased in e-MSCs
With regard to commonly up-regulated genes in e2-and e5-MSCs, 363 genes were extracted (Fig. 3A) . GO analysis showed that commonly up-regulated genes were significantly included in the GO term of "Cell chemotaxis" (accession number 0060326, chemokine family members such as CXCL1, CXCL2, CXCL5, and CXCL6 was greatly increased. On the other hand, the expression of CXCL12 was greatly decreased among CXC chemokine family members (Fig. 3C ). qRT-PCR analysis validated the decrease in mRNA expression of CXCL12 (Fig. 3D ). This was further confirmed in e2-and e5-MSCs derived from different BM-MSC lots (Fig. S4B) . In contrast to the remarkable change in expression of CXC chemokine family members, the expression of C-C motif (CC) chemokine family members did not apparently change (Fig. 3E ).
Osteoinductive stimulation favors in vivo hematopoietic recovery after BM transplantation
Our in vitro data suggested that e-MSCs enhance the expansion of hematopoietic cells; therefore, we hypothesized that osteoinductive stimulation could support hematopoietic recovery after chemotherapy, radiotherapy, and BM transplantation. To investigate the possibility of clinical application, we administered OICS or vehicle to lethally irradiated (9 Gy) C57BL/6 mice for 7 days after BM transplantation ( Fig. 4A ). Although two of six vehicle-treated mice died at day 10 or 12 after transplantation, all OICS-treated mice survived for more than 1 month. The WBC number and Hb levels at 10 days after BM transplantation were significantly higher in OICS-treated mice than in vehicle-treated mice, implying that OICS rescued the recipient mice from death due to cytopenia-related complications ( Fig. 4B-C ).
Discussion
Raaijmakers et al. [11] 
Conflicts of interest
There is no conflict of interest. 
Supplemental data
Supplemental information can be found in the online version of this article. Supplementary Tables •   Supplementary Table 1 Supplementary Materials and Methods
Adipogenic differentiation assay of BM-MSCs
To induce adipogenic differentiation of BM-MSCs, 0.5 mM isobutyl-methylxanthine, 60 µM indomethacin, 0.5 µM hydrocortisone, and 10 µg/mL insulin (all from Sigma-Aldrich) were added to the culture media. Oil Red O staining was used to assess lipid-laden fat cells. The number of Oil Red O + cells was quantitated, as previously described [12] . Images were acquired using a Biozero BZ-8100 microscope and BZ Viewer software (both from Keyence, Osaka, Japan).
qRT-PCR
Total RNA was extracted using the QIAamp RNA Blood Mini Kit (Qiagen Japan, Tokyo, Japan) and subjected to reverse transcription. The 10 µL PCR mixture contained Taqman Fast Universal PCR master mix (Applied Biosystems, Carlsbad, CA), cDNA, primer pairs, and the Taqman probe (Universal Probe Library). cDNA was amplified with the StepOne Plus Real-Time PCR system (Applied Biosystems) using the following parameters: 95°C for 20 seconds, followed by 40 cycles of 95°C for 1 second and 60°C for 20 seconds. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used as an internal control to normalize any loading differences. The primer sets and universal probes used are listed in Supplementary Table 3 . 
